Patents Assigned to THERAPHARM GMBH
  • RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES
    Publication number: 20220401594
    Abstract: The present invention relates to the use of radioimmunoconjugates for the treatment of bone marrow associated diseases, particularly AL-amyloidosis.
    Type: Application
    Filed: August 22, 2022
    Publication date: December 22, 2022
    Applicant: TheraPharm GmbH
    Inventors: Kim ORCHARD, Klaus BOSSLET
  • RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES
    Publication number: 20190388571
    Abstract: The present invention relates to the use of radioimmunoconjugates for the treatment of bone marrow associated diseases, particularly AL-amyloidosis.
    Type: Application
    Filed: January 23, 2018
    Publication date: December 26, 2019
    Applicant: TheraPharm GmbH
    Inventors: Kim ORCHARD, Klaus BOSSLET
  • Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies
    Patent number: 9072797
    Abstract: The present invention relates to the use of radioimmunoconjugates for the treatment of haematological malignancies, particularly multiple myeloma.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: July 7, 2015
    Assignee: THERAPHARM GMBH
    Inventors: Ivan Benes, Klaus Bosslet, Kim Orchard
  • Method of Preparing or Synthesizing Polyazamacrocycle Derivatives
    Publication number: 20080312430
    Abstract: The present invention relates to novel processes for the synthesis of polyazamacrocycle derivatives. Furthermore, the present invention relates to novel polyazamacrocycle derivatives as well as novel intermediates for the synthesis of said polyazamacrocycle derivatives.
    Type: Application
    Filed: October 20, 2005
    Publication date: December 18, 2008
    Applicant: THERAPHARM GMBH
    Inventors: Simon Cihelnik, Ladislav Droz, Martin Sramek